Skip to main content
. 2021 Jul 3;62(2):354–362. doi: 10.1007/s12016-021-08862-5

Table 3.

Multivariate analysis including classic cardiovascular risk factors, triple positivity, and thrombocytopenia

Model OR (95% CI) p value AUC (%)
M0 89.7
  Smoking 10.25 (2.18–48.24) 0.003
  HBP 8.74 (1.57–48.82) 0.014
  Dyslipidemia 2.87 (0.53–15.47) 0.220
  Triple positivity a 2.31(0.28–19.08) 0.438
  Thrombocytopenia 4.09 (0.57–28.05) 0.159
M1 89.9
  Smoking 11.00 (2.38–50.53) 0.002
  HBP 6.92 (1.36–35.29) 0.020
  Dyslipidemia 3.63 (0.71–18.52) 0.121
  Triple positivity a 5.20 (1.00–27.08) 0.050
M2
  Smoking 10.12 (2.19–46.80) 0.003 89.1
  HBP 9.77 (1.80–53.17) 0.008
  Dyslipidemia 2.73 (0.52–14.25) 0.233
  Thrombocytopenia 6.29 (1.27–31.02) 0.024
M3 89.1
  Smoking 11.69 (2.55–53.54) 0.002
  HBP 13.03 (2.66–63.72) 0.002
  Triple positivitya 2.11 (0.28–16.13) 0.473
  Thrombocytopenia 5.11 (0.78–33.35) 0.088
M4 86.4
  Smoking 11.25 (2.54–49.89) 0.001
  HBP 7.30 (1.50–35.46) 0.014
  Dyslipidemia 3.67 (0.77–17.57) 0.103
M5 86.2
  Smoking 12.38 (2.78–55.26) 0.001
  HBP 10.64 (2.37–47.71) 0.002
  Triple positivitya 5.30 (1.06–26.51) 0.042
M6 89.2
  Smoking 11.48 (2.54–51.87) 0.002
  HBP 14.19 (2.94–68.56) 0.001
  Thrombocytopenia 7.40 (1.55–35.20) 0.012

OR odds ratio, CI confidence interval, AUC area under the curve, HBP high blood pressure

aSingle or double versus triple